Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients

CABG Clinical Trial

Official title:

Effects of Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05285865
• Other study ID #: REC/01278 Sakina Asghar
• Status: Completed
• Phase: N/A
• Start date: March 15, 2022
• Est. completion date: July 1, 2023

Study information

• Verified date: August 2023
• Source: Riphah International University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To determine the effects of scapular mobilization on pulmonary functions of post-CABG patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: July 1, 2023
• Est. primary completion date: February 10, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 70 Years

Eligibility

Inclusion Criteria:

• CAD patients undergone CABG surgery (Post-Op. Day#. 01).
• Both genders (male and female).
• Aged between 40 to 70 years .
• Patient having oxygen saturation (SPO2) of more than or equal to 90% with 25% of fraction of inspired oxygen (FiO2) - (possibly nasal cannula inserted).

Exclusion Criteria:

• Patients with low glasgow coma scale (GCS) score (less than 15).
• Patients having inspiratory capacity of 3500ml and above.
• Patients on ventilator.

Related Conditions & MeSH terms

• CABG
• Respiratory Aspiration

Intervention

Other:
• Conventional Treatment
Thrice a day for complete length of stay. This is Conventional treatment The total duration of session will be of 15-20 mins.
• Scapular Mobilization
Thrice a day for complete length of stay including two sets of repetitions with a rest interval of 30 seconds between sets. Grade 1-3 As reported in a study Scapular mobilization (SM) i.e., Scapular superior, inferior glides, upward and downward rotations and scapular distraction, along with Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.

Locations

Country	Name	City	State
Pakistan	Rehman Medical Institute	Peshawar	KPK

Sponsors (1)

Lead Sponsor	Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incentive Spirometer	An incentive spirometer is a device that will expand the lungs by helping the patient breathe more deeply and fully	1 week
Primary	Borg scale	The Borg Rating of Perceived Exertion (RPE) is a way of measuring physical activity intensity level.	1 week
Primary	Numeric pain rating scale	What is a numerical pain rating scale? The Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain	1 week
Primary	Digital Spirometer	Spirometer is a portable lung function testing device, which mainly used to examine lung function related parameters for patients	1 week